Clinical Trial

Reducing Cognitive Impairment by Management of Heart Failure as a Modifiable Risk Factor

Study acronym: Cog-HF
Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated August 12, 2024 (before its estimated October 2025 completion). Its status may not reflect the trial's current state.
Summary
This study will test the feasibility and effectiveness of an innovative model of care for cognitively impaired patients with heart failure. This program aims to improve cognition, reduce dementia risk and cardiovascular events, and will be supported by innovative digital technology for wide scale rollout and implementation. Findings from this research will transform the way healthcare is delivered to cognitively impaired patients with heart disease who have a very high risk of developing dementia.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-09
Trial Details
NCT Number NCT06088212
Lead Sponsor Baker Heart and Diabetes Institute
Conditions Heart Failure, Cognitive Impairment, Dementia, Left Ventricular Dysfunction, Cognitive Change, Cognitive Decline
Enrollment 168 participants
Start Date 2024-07-01
Primary Completion 2025-10 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2024-08-12